Samarium-153 EDTMP therapy of disseminated skeletal metastasis.

European Journal of Nuclear Medicine
J H TurnerP G Claringbold

Abstract

153Sm-EDTMP (ethylenediaminetetramethylene phosphonate), prepared from a kit, was administered to 28 patients in a clinical trial of therapy for painful skeletal metastases unresponsive to all conventional treatment. The 103 keV gamma emission of 153Sm was utilized for prospective individual estimation of beta radiation absorbed dose to red marrow to minimize myelotoxicity and provide optimum internal radiotherapy to skeletal metastases in each patient. Pain relief occurred within 14 days of administration of 153Sm-EDTMP in 15 of 19 patients (79%) who could be evaluated at 6 weeks, when clinical response was maximal. Duration of response ranged from 4 to 35 weeks. Recurrence of pain responded to retreatment with 153Sm-EDTMP in five of eight cases. No dose-response relationship was apparent for pain relief but reversible myelotoxicity was frequently observed at radiation absorbed doses to bone marrow greater than or equal to 270 cGy. Dosimetry calculation was based on pharmacokinetic studies of a tracer administration of 153Sm-EDTMP in each patient. Assumptions inherent in this prospective method of predicting dose to bone marrow were validated experimentally. Biodistribution studies in rats demonstrated rapid skeletal uptake an...Continue Reading

Citations

Jan 1, 1990·European Journal of Nuclear Medicine·A M Verbruggen
Jan 1, 1993·European Journal of Nuclear Medicine·V J Lewington
Jan 24, 2007·European Journal of Nuclear Medicine and Molecular Imaging·L StrigariC L Maini
Aug 30, 2008·European Journal of Nuclear Medicine and Molecular Imaging·L BianchiL Pozzi
Sep 28, 2004·Journal of Cancer Research and Clinical Oncology·Knut LiepeJörg Kotzerke
Jan 10, 2012·Annals of Nuclear Medicine·J Harvey Turner
Apr 4, 2003·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Piotr GarnuszekAnna Kamińska
Mar 31, 1998·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·B E ZimmermanF J Schima
Apr 27, 2001·Nuclear Medicine and Biology·J E BugajA Srinivasan
Nov 1, 1996·Nuclear Medicine and Biology·W K LouwA van Aswegen
Jun 10, 1998·Nuclear Medicine and Biology·A Mushtaq
Feb 24, 2001·Seminars in Nuclear Medicine·I SarikayaL E Holder
Jul 1, 2011·Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India·Krishnakumar Ramachandran Rangarajan
Apr 1, 2014·Archives of Medical Research·Luis Correa-GonzálezLuis Correa-Hernández
Sep 1, 1991·The British Journal of Radiology·A H LaingM A Zivanovic
Oct 7, 2000·Annals of Nuclear Medicine·N O KüçükA Soylu
Jan 1, 1995·Acta Oncologica·O S Bruland
Jan 1, 1996·Acta Oncologica·T Möller
Sep 25, 2010·Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)·L VignaM Brambilla
Feb 17, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Nathan LawrentschukAndrew M Scott
Feb 1, 1992·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·G J BeyerF Rösch
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J H Turner, P G Claringbold
Jun 27, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Malay ChatterjeePierfrancesco Tassone
Jul 25, 2006·Expert Opinion on Pharmacotherapy·Pete Anderson
May 10, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Edward ChowCyril Danjoux
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter M AndersonOyvind S Bruland
Nov 24, 2004·São Paulo Medical Journal = Revista Paulista De Medicina·Elba Cristina Sá de Camargo EtchebehereEdwaldo Eduardo Camargo
Jan 18, 2005·Revista do Hospital das Clínicas·Marcelo Tatit SapienzaCarlos Alberto Buchpiguel
May 23, 1998·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·V Rodriguez, D Betcher
Oct 4, 2005·American Journal of Clinical Oncology·Venugopal DamerlaVani Vijayakumar
Mar 13, 2002·Drugs & Aging·R C PelgerN A Hamdy
Feb 22, 2000·American Journal of Clinical Oncology·C GiannakenasP J Vassilakos
Aug 19, 2020·Journal of Clinical Medicine·Reyhaneh Manafi-FaridMohsen Beheshti
Feb 20, 2002·Clinical Nuclear Medicine·Naresh VermaWai-Ling Chan
Apr 21, 2004·Nuclear Medicine Communications·Barbara J FuegerChristian Pirich
May 14, 2009·Langmuir : the ACS Journal of Surfaces and Colloids·David R JansenGerard C Krijger
Sep 1, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Pradeep ThapaSandip Basu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved